Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.

T Eisen, G Hedlund, G Forsberg, R Hawkins

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	370-371
Number of pages	1
Journal	Current Oncology Reports (Print)
Volume	16
Issue number	2
DOIs	https://doi.org/10.1007/s11912-013-0370-0
Publication status	Published - Feb 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e35634b52ced474ea55f057daec859a8,

title = "Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.",

author = "T Eisen and G Hedlund and G Forsberg and R Hawkins",

year = "2014",

month = feb,

doi = "10.1007/s11912-013-0370-0",

language = "English",

volume = "16",

pages = "370--371",

journal = "Current Oncology Reports (Print)",

issn = "1523-3790",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.

AU - Eisen, T

AU - Hedlund, G

AU - Forsberg, G

AU - Hawkins, R

PY - 2014/2

Y1 - 2014/2

U2 - 10.1007/s11912-013-0370-0

DO - 10.1007/s11912-013-0370-0

M3 - Article

SN - 1523-3790

VL - 16

SP - 370

EP - 371

JO - Current Oncology Reports (Print)

JF - Current Oncology Reports (Print)

IS - 2

ER -